NIP
NXTM

Nicholas Investment Partners’s NxStage Medical Inc. NXTM Stock Holding History

Nicholas Investment Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-105,287
Closed -$2.76M – 312
2016
Q4 		$2.76M Sell
105,287
-42,291
-29% -$1.05M 0.21% 195
2016
Q3 		$3.69M Buy
147,578
+59,796
+68% +$1.39M 0.25% 163
2016
Q2 		$1.9M Buy
+87,782
New +$1.57M 0.13% 259

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Nicholas Investment Partners's NXTM Position: Q1 2017 in Review

Nicholas Investment Partners sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 105,287 shares — an estimated $2.76M sold.

Nicholas Investment Partners first reported a position in NXTM in Q2 2016 and held it in 3 quarters. The position peaked at $3.69M in Q3 2016. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

  • Nicholas Investment Partners reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
  • Nicholas Investment Partners sold 105,287 NxStage Medical Inc. shares in Q1 2017, an estimated $2.76M.
  • Nicholas Investment Partners first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 3 quarters.
  • Nicholas Investment Partners's NxStage Medical Inc. position peaked at $3.69M in Q3 2016.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Nicholas Investment Partners's 13F filing for Q1 2017, filed 15 May 2017.